Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Robust Rat and Mouse Models of Bilateral Renal Ischemia Reperfusion Injury

TANYA SMITH, AELIYA ZAIDI, CHARLOTTE VICTORIA MAYNARD BROWN, GILDA PINO-CHAVEZ, TIMOTHY BOWEN, SOMA MERAN, DONALD FRASER, RAFAEL CHAVEZ and USMAN KHALID
In Vivo May 2024, 38 (3) 1049-1057; DOI: https://doi.org/10.21873/invivo.13538
TANYA SMITH
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
2Department of Anesthetics, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: smithta3@cardiff.ac.uk
AELIYA ZAIDI
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
3Cardiff Transplant Unit, Nephrology & Transplant Directorate, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLOTTE VICTORIA MAYNARD BROWN
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
3Cardiff Transplant Unit, Nephrology & Transplant Directorate, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GILDA PINO-CHAVEZ
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TIMOTHY BOWEN
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOMA MERAN
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DONALD FRASER
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFAEL CHAVEZ
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
3Cardiff Transplant Unit, Nephrology & Transplant Directorate, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
USMAN KHALID
1Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, U.K.;
3Cardiff Transplant Unit, Nephrology & Transplant Directorate, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: usman.khalid@doctors.org.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Acute and chronic kidney diseases are a major contributor to morbidity and mortality worldwide, with no specific treatments currently available for these. To enable understanding the pathophysiology of and testing novel treatments for acute and chronic kidney disease, a suitable in vivo model of kidney disease is essential. In this article, we describe two reliable rodent models (rats and mice) of efficacious kidney injury displaying acute to chronic kidney injury progression, which is also reversible through novel therapeutic strategies such as ischemic preconditioning (IPC). Materials and Methods: We utilized adult male Lewis rats and adult male wildtype (C57BL/6) mice, performed a midline laparotomy, and induced warm ischemia to both kidneys by bilateral clamping of both renal vascular pedicles for a set time, to mimic the hypoxic etiology of disease commonly found in kidney injury. Results: Bilateral ischemia reperfusion injury caused marked structural and functional kidney injury as exemplified by histology damage scores, serum creatinine levels, and kidney injury biomarker levels in both rodents. Furthermore, this effect displayed a dose-dependent response in the mouse model. Conclusion: These rodent models of bilateral kidney IRI are reliable, reproducible, and enable detailed mechanistic study of the underlying pathophysiology of both acute and chronic kidney disease. They have been carefully optimised for single operator use with a strong track record of training both surgically trained and surgically naïve operators.

Key Words:
  • Kidney injury
  • ischemia reperfusion injury
  • mouse
  • rat

Ischemia reperfusion injury (IRI) is a major contributor to acute kidney injury (AKI) following which, failed kidney recovery may progress to chronic kidney disease (CKD)(1), costing the National Health Service (NHS) £1.45 billion every year (2). Currently, there are no specific treatments for those with AKI and the mechanisms behind subsequent recovery versus progressive fibrosis remain poorly defined. As a clinically important cause of kidney injury, IRI is widely studied experimentally. A variety of techniques exist to model AKI, including toxin-induced nephropathy (e.g., aristolochic acid, gentamicin, cisplatin, high dose folic acid, warfarin, and glycerol), and surgical models (e.g., unilateral ureteral obstruction, renal mass reduction and renal vascular pedicle clamping) (3).

There are several surgical IRI models of kidney injury including unilateral IRI, bilateral IRI and unilateral IRI with contralateral nephrectomy, with specific advantages and disadvantages of each method. We advocate the use of a surgical model that involves the direct and timed clamping of both renal pedicles (bilateral IRI). This is because it more closely mimics the bilateral injury seen in human diseases and permits subsequent functional evaluation of kidney injury. Unilateral models rarely reflect the severity of injury, as remodeling and adaptive processes occur in the remaining kidney (4). This has led many investigators to combine unilateral IRI with a second injury, such as nephrectomy or ureteric obstruction. The unilateral model with combined contralateral nephrectomy (used as a control) is a commonly utilized model. However, this requires very mild injury to ensure animal survival and is a non-functional model of modelling disease. In our opinion, sham animals provide ideal controls and a bilateral IRI model more accurately reflects the process of kidney injury seen in the clinical setting. Finally, our approach differs from other surgical IRI models utilizing flank incisions to gain access to the kidneys. We chose to use a midline laparotomy to gain access to the full abdominal cavity, as this allows excellent exposure of the operative field and easy access to both renal pedicles for accurate dissection and clamping.

Our overall aim was to characterize functional and structural kidney injury from the acute phase (AKI) through to its progression to CKD, mimicking human pathology, and secondly for this injury to be potentially reversible to enable testing of novel therapeutic strategies. In this study, we describe two rodent models (mouse and rat) of efficacious, recoverable and mild-moderate kidney injury that displays AKI secondary development of fibrosis compatible with progression to CKD.

Materials and Methods

Rodents and animal care. Eight-week-old Male adult Lewis Rats weighing approximately 180-240g (Charles River Laboratories, Bristol, UK) and Male adult C57BL/6 mice weighing >15 g (Charles River Laboratories) were purchased and maintained in an animal house with free access to water and pelleted food. All animal experiments were conducted according to the United Kingdom Use of Animals (Scientific Procedures) Act 1986, under license P6B0CD326. The animals were given a seven-day period of acclimatization to their new surroundings and were housed and handled according to the local institutional policies and procedures licensed by the Home Office. Ethical approval for all the protocols within the License was provided by the Animal Welfare and Ethical Review Body under the Establishment License held by Cardiff University. The ARRIVE guidelines were followed for all experiments involving use of animals.

Surgical techniques. See Table I, for further details. The animals underwent thorough health checks before transfer to individual cages 24 h prior to the intended surgical procedure. Analgesia was provided to individual animals 24 h prior to any surgical intervention until the time of tissue retrieval in the form of 200 mcg of buprenorphine (Sansoz, Camberley, UK, PC 05050650092042) dissolved in 500 ml of drinking water. Anesthesia was provided in the induction chamber using a combination of 5% isoflurane in oxygen at a rate of 2-3 ml/min. The animal was placed in a supine position, immobilized with plain surgical tape. Maintenance anesthesia was provided via tube mask covering the face by approximately 2% isoflurane delivered with approximately 1-2 ml/min oxygen. For rats, 0.3-0.4 ml of blood was taken from tail vein once the animal was fully anesthetized.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Detailed protocol for surgical bilateral ischemia reperfusion injury in the mouse and rat model.

The abdomen was prepared by the removal of excess fur from the abdomen with hair trimmers. Under aseptic conditions, a midline laparotomy was performed. Once safe access to peritoneal cavity was achieved, bowels are moved to the right side gently with sterile cotton buds. The left kidney renal vascular pedicle was identified, dissected out (with fine forceps with curved tips) and clamped under direct vision with a microvascular clamp. The bowels were then moved to the left and the same process was done for the right kidney renal vascular pedicle. Care was taken to avoid any damage to surrounding structures. If IPC was utilized, this can be performed according to our previous methods (5). The kidneys were visually assessed for macroscopic ischemic injury which is evidenced by change in color from a normal pink to purplish brown. Each clamp was removed after exactly the specified time of ischemia for each kidney according to the experiment (e.g., 20 min for mice and 45 min for rats). The kidneys were visually assessed again for return of color to pink. Rectus sheath and skin were closed with absorbable (4/0 vicryl) continuous sutures. Sham controls underwent the same operation without the renal pedicle clamping. At the completion of the procedure, anesthesia was disconnected, and the animal was observed closely until full recovery.

At the end of assigned time point for culling (1 to 28 days), animals were again anesthetized using combination of isoflurane and oxygen, positioned on the operating board, and maintenance anesthesia was delivered as mentioned above. Midline wound was opened followed by opening of the pleura to gain access to the chest cavity. Total blood circulating volume was aspirated from the heart by direct puncture to cause exsanguination (and confirmation of permanent cessation of the circulation was made by surgical excision of the heart. Each kidney was carefully removed using dissecting scissors and placed in a receptacle for tissue processing and storage. Anesthesia was disconnected and the animal carcass was then packed to be disposed of as per the animal unit (Joint Biological Services Unit, Cardiff University) guidelines and procedures.

Histology. Kidney tissue was embedded in paraffin and sectioned for Hematoxylin and eosin (H&E) staining. Scoring was carried out in a blinded fashion using the Endothelial, Glomerular, Tubular, and Interstitial (EGTI) scoring system, developed specifically for animal research on kidney tissue in the context of injury (5, 6).

Renal function. Serum creatinine was measured in blood samples of rats taken pre-operatively (at 0 h) and in samples from rats and mice at time of retrieval using the Jaffe reaction.

RT-qPCR. Whole kidney tissue was stored in RNA later solution immediately at time of retrieval and frozen at −80°C. Total RNA was extracted using TRIzol reagent (Cat. No. 15596018; Life Technologies, Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to manufacturer’s instructions. RNA quality was assessed using the Agilent 2100 Bioanalyzer with RNA 6000 Nano chips (Santa Clara, CA, USA) and quantified prior to RT-qPCR. cDNA was generated using a High-Capacity Reverse Transcription Kit (Cat. No. 4368814; Life Technologies) with random primers. RT-qPCR was performed on a ViiA7 Fast Real-Time PCR System (Life Technologies). Primer sequences: NGAL (forward: 5’-GGGCTGTCCGATGAACTGAA-3’; reverse: 5’-CATTGGTCGGTGGGAACAGA-3’) and KIM-1 (forward: 5’CGGCTAACCAGAGTGACTTGT-3’; reverse: 5’-TACAGAGCCTGGAAGAAGCAG-3’) were quantified using POWER SYBR GREEN PCR Master Mix (Cat. No. 4368706; Life Technologies) with gene-specific primers, normalized to GAPDH (forward: 5’-CCTCTGACTTCAACAGCGACAC- 3’; reverse: 5’-TGTCATACCAGGAAATGAGCTTGA-3’), as previously described (5, 6).

Statistical analysis. Statistical analyses were performed using GraphPad Prism v10 software (San Diego, CA, USA). Data are expressed as mean±SD or median (and range) and assessed for statistical significance using unpaired Student’s t-test or Mann-Whitney U-test.

Results

This procedure has been adapted in both male and female rat and mouse strains. We have successfully used rats aged 10-20 weeks weighing 150-400 g, and mice aged 10 weeks – 1 year weighing over 15 g.

The model of IRI is a stepwise process (Figure 1 and Figure 2) that enables the assessment of induced kidney disease. Animals were randomly allocated by random number generator on the day of the experiment into either sham or IRI groups until each experimental group was complete (n=5 per group), data analysis was performed by the operator. Animals were kept in the same living and maintenance facility to reduce the influence of external confounders. All experiments were performed blinded to group allocation until the point of data analysis.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Mouse model of ischemia reperfusion injury from maintenance of anesthesia to skin closure. A) Maintenance of anesthesia. B) Positioning and stabilizing the mouse. C) Exposure of the peritoneal cavity. D) The left kidney renal vascular pedicle is identified and dissected. E) Left kidney vascular pedicle clamped under direct vision with a microvascular clamp. F) Right kidney vascular pedicle clamped under direct vision with a microvascular clamp. G) Closure of the rectus sheath with continuous stitches. H) Closure of the skin. Note that sham animals undergo the same procedure without the renal vascular pedicle clamping.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Rat model of ischemia reperfusion injury demonstrating some aspects of the procedure. A) Rats were housed in conventional cages with readily available rat chow and water. B) Isoflurane anesthesia was delivered via an induction chamber. C) The central abdomen was shaved, and the rat positioned on a cork board covered in sterile drape. D) The abdomen was opened, and custom-made retractors were used to optimize visibility. E) The bowels were moved to the right side to allow visualization and clamping of the left renal pedicle. Ischemia was confirmed by the dark discoloration of the kidney. F) Following the procedure, the abdomen was closed using a two-layer technique.

The effect of IRI was dose-dependent as shown in the mouse model, where increasing durations of renal pedicle clamping increases the kidney injury response according to the established biomarkers of kidney disease: serum creatinine, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1). In addition, quantitative histological analysis was included to validate the effects of acute injury seen at 48 h (Figure 3, Figure 4, Figure 5). Mouse and rat IRI models both showed increases in creatinine, KIM-1, NGAL and histology damage scores when compared to sham animals. In both models, we reliably reproduced mild-moderate kidney injury which WAS not present in sham animals. Although serum creatinine levels were increased in surgical IRI groups, NGAL, KIM-1 or histology damage scores may better reflect severity of disease.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Histological analysis of mouse and rat renal cortex in both sham (control) and IRI models. Kidney tissue was embedded in paraffin and sectioned for hematoxylin and eosin (H&E) staining. Sections from the mouse and rat were examined using a Leica DMLA Light Microscope. Representative photographs were taken using an Olympus DP27 Microscope Digital Camera. Representative renal cortex mouse and rat histology in ischemia reperfusion injury (IRI) (20 min in the mouse 45 min in the rat) and sham animals, 48 h (Acute) and 28 days (Chronic) after injury. H&E micrographs (×200) show normal appearance in sham (A, C, E and G), and moderate to significant damage in both mouse and rat IRI models (B, D, F and H). Scale bar=50 mm.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Effect on Endothelial, Glomerular, Tubular, and Interstitial (EGTI) histology damage score, serum creatinine and renal injury markers NGAL and KIM-1 48 h after ischemia reperfusion injury (IRI) in the mouse (20 min; n=5 sham n=5 IRI (total 10 mice) and 48 h after IRI in the rat (45 min; n=5 sham n=5 IRI (total 10 rats). Serum creatinine, NGAL and KIM-1 was measured after 24-48 h and is plotted as mean±SD and analyzed by unpaired Student’s t-test. Categorical data are expressed as median (and range) and analyzed using Mann-Whitney U-test. Significance level was pre-specified as p-value<0.05 and is annotated where this threshold is met. RT-qPCR analysis of NGAL and KIM-1 was performed following RNA extraction from whole kidney tissue and expression was normalized to GAPDH.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Mouse creatinine [n=5 sham, n=5 ischemia reperfusion injury (IRI); 10 mice in total] and Endothelial, Glomerular, Tubular, and Interstitial (EGTI) histology scores (n=5 sham, n=1 IRI 10 min, n=3 IRI 15 min, n=3 IRI 15 min, n=5 IRI 25 min) for varying durations of IRI (10-25 min) compared to sham mice (control). Paired kidneys analyzed from the same animal and plotted as right (R) or left (L) kidney above. Categorical data are expressed as median (and range) and analyzed using the Mann-Whitney U-test. A. Creatine levels after IRI. EGTI histology scores in both the right and left kidney after 10-15 min of IRI.

When considering which rodent model to use, there are clear differences in the responses between the mouse and rat model. These differences can be strain dependent, therefore optimization of the duration of IRI should be considered in different rodent strains.

Discussion

Although a variety of species have been used to model kidney disease (4, 7-10), we chose to develop both rat and mouse models of IRI. Rodents in general are reliable animals, easy to breed, simple to maintain within an institutional infrastructure and well tested over a variety of conditions and timepoints (11). In comparison to mice, rats are generally larger therefore, easier to operate on, easier for administration of novel drugs and test therapeutic interventions. Mice are much smaller, and marginally more challenging to operate on due to their size. However, they allow for evaluation of specific genes of interest due to a greater availability of transgenic and genetically modifiable strains.

Our model has been shown to produce functionally and structurally evident kidney injury and support the testing of novel treatment strategies such as Ischemic Preconditioning (IPC) in both acute and chronic injury in the rat model (5, 12). Moreover, we have previously shown that, by employing laser capture microdissection for isolation and analysis of specific cell types on tissue samples, this protective IPC signal originates from the proximal tubular cells (5). These animals typically recover very well from the surgery with minimal adverse outcomes (Table II). The ability of these models to demonstrate robust kidney injury (both AKI and chronic fibrosis) and then attenuate it with effective treatment strategies, makes them very attractive to study kidney disease and test treatments.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Table of expected adverse outcomes.

There are some limitations worthy of note implicated with the use of this surgical animal model, including the cost of maintenance, surgical training time and translation to human pathology. However, by adhering to the principles of the 3Rs of reduction, replacement, and refinement (13), these limitations are offset by the ability of these models to advance our understanding of disease and accelerate drug discovery and development of novel therapeutics. Furthermore, these refined models allow for replacement of non-functional models of AKI.

There are significant advantages of using these rodent bilateral renal IRI models. First, rats and mice are easy to maintain and house. Larger mammal species require a more expensive and labor intensive set up, limiting their use. Although, this is a surgical model that is amenable to both unilateral and bilateral injury, the bilateral model more closely mimics the clinical disease and is preferred. In addition, it allows for both functional and structural evaluation of kidney injury which is only possible in the bilateral model. Furthermore, this model is well validated by a range of research groups, with reliable and reproduceable results across many species. Our model has been designed over several years to enable single operator use and it has been used extensively within our research group with minimal complications. These animal models enable us to investigate complex disease processes in a controlled environment.

Conclusion

We present the iterative development of a protocol for bilateral IRI in mice and rats. The protocol can be adapted to support bilateral protective ischemic preconditioning, indirect preconditioning utilizing ischemia of muscle, or intraperitoneal/intravenous/subcutaneous drug administration.

Acknowledgements

The Authors would like to thank the JBIOS staff at Cardiff University for supporting this project.

Footnotes

  • Authors’ Contributions

    R.C., D.F., and U.K. conceived and designed the research. T.S., A.Z., C.V.M.B., and U.K. conducted data collection and collected samples. U.K. and G.P.C. performed sample and data analysis. T.S., A.Z., D.F., and U.K. wrote the manuscript, D.F, T.B, R.C, and S.M. reviewed the manuscript. All Authors read and approved the final manuscript.

  • Conflicts of Interest

    The Authors declare no competing interests in relation to this study.

  • Funding

    This work was supported by Health and Care Research Wales funding. TS is in receipt of a clinical training fellowship funded by Kidney Research UK. There was no role of the funding bodies in the design of the study, in the collection, analysis, interpretation of data or in writing of the manuscript.

  • Received January 5, 2024.
  • Revision received February 5, 2024.
  • Accepted February 12, 2024.
  • Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

    1. Kinsey GR,
    2. Li L,
    3. Okusa MD
    : Inflammation in acute kidney injury. Nephron Exp Nephrol 109(4): e102-e107, 2008. DOI: 10.1159/000142934
    OpenUrlCrossRefPubMed
  1. ↵
    1. Kerr M,
    2. Bray B,
    3. Medcalf J,
    4. O’Donoghue DJ,
    5. Matthews B
    : Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 27 Suppl 3(Suppl 3): iii73-iii80, 2012. DOI: 10.1093/ndt/gfs269
    OpenUrlCrossRefPubMed
  2. ↵
    1. Bao YW,
    2. Yuan Y,
    3. Chen JH,
    4. Lin WQ
    : Kidney disease models: tools to identify mechanisms and potential therapeutic targets. Zool Res 39(2): 72-86, 2018. DOI: 10.24272/j.issn.2095-8137.2017.055
    OpenUrlCrossRef
  3. ↵
    1. Godoy JR,
    2. Watson G,
    3. Raspante C,
    4. Illanes O
    : An effective mouse model of unilateral renal ischemia-reperfusion injury. JoVE (173), 2021. DOI: 10.3791/62749
    OpenUrlCrossRef
  4. ↵
    1. Khalid U,
    2. Jenkins RH,
    3. Andrews R,
    4. Pino-Chavez G,
    5. Cossins BC,
    6. Chavez R,
    7. Bowen T,
    8. Fraser DJ
    : Determination of a microRNA signature of protective kidney ischemic preconditioning originating from proximal tubules. Sci Rep 11(1): 9862, 2021. DOI: 10.1038/s41598-021-89195-3
    OpenUrlCrossRef
  5. ↵
    1. Khalid U,
    2. Jenkins RH,
    3. Pino-Chavez G,
    4. Bowen T,
    5. Fraser DJ,
    6. Chavez R
    : A localized ischemic preconditioning regimen increases tumor necrosis factor α expression in a rat model of kidney ischemia-reperfusion injury. Exp Clin Transplant 13: 535-542, 2015.
    OpenUrl
  6. ↵
    1. Hesketh EE,
    2. Czopek A,
    3. Clay M,
    4. Borthwick G,
    5. Ferenbach D,
    6. Kluth D,
    7. Hughes J
    : Renal ischaemia reperfusion injury: a mouse model of injury and regeneration. J Vis Exp (88): 51816, 2014. DOI: 10.3791/51816
    OpenUrlCrossRef
    1. Shiva N,
    2. Sharma N,
    3. Kulkarni YA,
    4. Mulay SR,
    5. Gaikwad AB
    : Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models. Life Sci 256: 117860, 2020. DOI: 10.1016/J.LFS.2020.117860
    OpenUrlCrossRef
    1. Huang J,
    2. Bayliss G,
    3. Zhuang S
    : Porcine models of acute kidney injury. Am J Physiol Renal Physiol 320(6): F1030-F1044, 2021. DOI: 10.1152/ajprenal.00022.2021
    OpenUrlCrossRef
  7. ↵
    1. Zhang J,
    2. Wang X,
    3. Wei J,
    4. Wang L,
    5. Jiang S,
    6. Xu L,
    7. Qu L,
    8. Yang K,
    9. Fu L,
    10. Buggs J,
    11. Cheng F,
    12. Liu R
    : A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice. Am J Physiol Renal Physiol 319(2): F304-F311, 2020. DOI: 10.1152/ajprenal.00017.2020
    OpenUrlCrossRef
  8. ↵
    1. Scarfe L,
    2. Menshikh A,
    3. Newton E,
    4. Zhu Y,
    5. Delgado R,
    6. Finney C,
    7. de Caestecker MP
    : Long-term outcomes in mouse models of ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 317(4): F1068-F1080, 2019. DOI: 10.1152/ajprenal.00305.2019
    OpenUrlCrossRef
  9. ↵
    1. Brown CVM,
    2. Pino-chavez G,
    3. Zaidi A,
    4. Grigorieva I,
    5. Woods E,
    6. Steadman R,
    7. Chavez R,
    8. Meran S,
    9. Khalid U
    : Ischaemic preconditioning attenuates chronic renal damage following ischaemia reperfusion injury. biorxiv, 2023. DOI: 10.1101/2023.07.13.548869
    OpenUrlCrossRef
  10. ↵
    1. Russell W,
    2. Burch R
    : The Principles of Humane Experimental Technique. London, UK, Methuen & Co Ltd., 1959.
PreviousNext
Back to top

In this issue

In Vivo: 38 (3)
In Vivo
Vol. 38, Issue 3
May-June 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Robust Rat and Mouse Models of Bilateral Renal Ischemia Reperfusion Injury
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Robust Rat and Mouse Models of Bilateral Renal Ischemia Reperfusion Injury
TANYA SMITH, AELIYA ZAIDI, CHARLOTTE VICTORIA MAYNARD BROWN, GILDA PINO-CHAVEZ, TIMOTHY BOWEN, SOMA MERAN, DONALD FRASER, RAFAEL CHAVEZ, USMAN KHALID
In Vivo May 2024, 38 (3) 1049-1057; DOI: 10.21873/invivo.13538

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Robust Rat and Mouse Models of Bilateral Renal Ischemia Reperfusion Injury
TANYA SMITH, AELIYA ZAIDI, CHARLOTTE VICTORIA MAYNARD BROWN, GILDA PINO-CHAVEZ, TIMOTHY BOWEN, SOMA MERAN, DONALD FRASER, RAFAEL CHAVEZ, USMAN KHALID
In Vivo May 2024, 38 (3) 1049-1057; DOI: 10.21873/invivo.13538
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Association of Matrix Metalloproteinase-7 Genotypes With Nasopharyngeal Carcinoma Risk
  • Age- and Periodontal Disease Independent Correlation of Salivary Amino Acids
  • Activation of Invariant Natural Killer T Cells Enhances Ischemia-Reperfusion Injury in Steatotic Mouse Livers
Show more Experimental Studies

Similar Articles

Keywords

  • Kidney injury
  • ischemia reperfusion injury
  • mouse
  • rat
In Vivo

© 2025 In Vivo

Powered by HighWire